Cargando…
Glucose Transporter 8 (GLUT8) Mediates Fructose-induced de Novo Lipogenesis and Macrosteatosis
Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease in the world, and it is thought to be the hepatic manifestation of the metabolic syndrome. Excess dietary fructose causes both metabolic syndrome and NAFLD in rodents and humans, but the pathogenic mechanisms of fructose-indu...
Autores principales: | DeBosch, Brian J., Chen, Zhouji, Saben, Jessica L., Finck, Brian N., Moley, Kelle H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Biochemistry and Molecular Biology
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4036240/ https://www.ncbi.nlm.nih.gov/pubmed/24519932 http://dx.doi.org/10.1074/jbc.M113.527002 |
Ejemplares similares
-
Improved Insulin Sensitivity by GLUT12 Overexpression in Mice
por: Purcell, Scott H., et al.
Publicado: (2011) -
SLC2A8 (GLUT8) is a mammalian trehalose transporter required for trehalose-induced autophagy
por: Mayer, Allyson L., et al.
Publicado: (2016) -
Hepatic de novo lipogenesis is suppressed and fat oxidation is increased by omega-3 fatty acids at the expense of glucose metabolism
por: Green, Charlotte J, et al.
Publicado: (2020) -
Growth Hormone Inhibits Hepatic De Novo Lipogenesis in Adult Mice
por: Cordoba-Chacon, Jose, et al.
Publicado: (2015) -
Maternal Fructose Diet-Induced Developmental Programming
por: Thompson, Michael D., et al.
Publicado: (2021)